218 related articles for article (PubMed ID: 23814052)
1. Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors.
Mehrotra S; Sharma B; Joshi S; Kroczynska B; Majchrzak B; Stein BL; McMahon B; Altman JK; Licht JD; Baker DP; Eklund EA; Wickrema A; Verma A; Fish EN; Platanias LC
J Biol Chem; 2013 Aug; 288(33):23814-22. PubMed ID: 23814052
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses.
Joshi S; Kaur S; Redig AJ; Goldsborough K; David K; Ueda T; Watanabe-Fukunaga R; Baker DP; Fish EN; Fukunaga R; Platanias LC
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12097-102. PubMed ID: 19574459
[TBL] [Abstract][Full Text] [Related]
3. Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis.
Joshi S; Sharma B; Kaur S; Majchrzak B; Ueda T; Fukunaga R; Verma AK; Fish EN; Platanias LC
J Biol Chem; 2011 Feb; 286(8):6017-26. PubMed ID: 21149447
[TBL] [Abstract][Full Text] [Related]
4. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis.
Verma A; Deb DK; Sassano A; Uddin S; Varga J; Wickrema A; Platanias LC
J Biol Chem; 2002 Mar; 277(10):7726-35. PubMed ID: 11773065
[TBL] [Abstract][Full Text] [Related]
5. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
6. Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses.
Sharma B; Joshi S; Sassano A; Majchrzak B; Kaur S; Aggarwal P; Nabet B; Bulic M; Stein BL; McMahon B; Baker DP; Fukunaga R; Altman JK; Licht JD; Fish EN; Platanias LC
J Biol Chem; 2012 Dec; 287(50):42352-60. PubMed ID: 23074222
[TBL] [Abstract][Full Text] [Related]
7. TGFβ-induced PI 3 kinase-dependent Mnk-1 activation is necessary for Ser-209 phosphorylation of eIF4E and mesangial cell hypertrophy.
Das F; Ghosh-Choudhury N; Bera A; Kasinath BS; Choudhury GG
J Cell Physiol; 2013 Jul; 228(7):1617-26. PubMed ID: 23359369
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Liu Y; Sun L; Su X; Guo S
Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
[TBL] [Abstract][Full Text] [Related]
10. JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response.
Kleppe M; Kwak M; Koppikar P; Riester M; Keller M; Bastian L; Hricik T; Bhagwat N; McKenney AS; Papalexi E; Abdel-Wahab O; Rampal R; Marubayashi S; Chen JJ; Romanet V; Fridman JS; Bromberg J; Teruya-Feldstein J; Murakami M; Radimerski T; Michor F; Fan R; Levine RL
Cancer Discov; 2015 Mar; 5(3):316-31. PubMed ID: 25572172
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function.
Lim S; Saw TY; Zhang M; Janes MR; Nacro K; Hill J; Lim AQ; Chang CT; Fruman DA; Rizzieri DA; Tan SY; Fan H; Chuah CT; Ong ST
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):E2298-307. PubMed ID: 23737503
[TBL] [Abstract][Full Text] [Related]
12. Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses.
Altman JK; Glaser H; Sassano A; Joshi S; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Tallman MS; Platanias LC
Mol Pharmacol; 2010 Oct; 78(4):778-84. PubMed ID: 20664001
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms.
Saleiro D; Wen JQ; Kosciuczuk EM; Eckerdt F; Beauchamp EM; Oku CV; Blyth GT; Fischietti M; Ilut L; Colamonici M; Palivos W; Atsaves PA; Tan D; Kocherginsky M; Weinberg RS; Fish EN; Crispino JD; Hoffman R; Platanias LC
Nat Commun; 2022 Apr; 13(1):1750. PubMed ID: 35365653
[TBL] [Abstract][Full Text] [Related]
14. The MNK-1/eIF4E pathway as a new therapeutic pathway to target inflammation and remodelling in asthma.
Seidel P; Sun Q; Costa L; Lardinois D; Tamm M; Roth M
Cell Signal; 2016 Oct; 28(10):1555-62. PubMed ID: 27418099
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
Konicek BW; Stephens JR; McNulty AM; Robichaud N; Peery RB; Dumstorf CA; Dowless MS; Iversen PW; Parsons S; Ellis KE; McCann DJ; Pelletier J; Furic L; Yingling JM; Stancato LF; Sonenberg N; Graff JR
Cancer Res; 2011 Mar; 71(5):1849-57. PubMed ID: 21233335
[TBL] [Abstract][Full Text] [Related]
16. Central role of ULK1 in type I interferon signaling.
Saleiro D; Mehrotra S; Kroczynska B; Beauchamp EM; Lisowski P; Majchrzak-Kita B; Bhagat TD; Stein BL; McMahon B; Altman JK; Kosciuczuk EM; Baker DP; Jie C; Jafari N; Thompson CB; Levine RL; Fish EN; Verma AK; Platanias LC
Cell Rep; 2015 Apr; 11(4):605-17. PubMed ID: 25892232
[TBL] [Abstract][Full Text] [Related]
17. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells.
Marzec M; Liu X; Wysocka M; Rook AH; Odum N; Wasik MA
PLoS One; 2011; 6(9):e24849. PubMed ID: 21949767
[TBL] [Abstract][Full Text] [Related]
19. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
Zaritsky LA; Bedsaul JR; Zoon KC
J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
